The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Roles of DNA topoisomerase II isozymes in chemotherapy and secondary malignancies
Open accessAbstract
Drugs that target DNA topoisomerase II (Top2), including etoposide (VP-16), doxorubicin, and mitoxantrone, are among the most effective anticancer drugs in clinical use. However, Top2-based chemotherapy has been associated with higher incidences of secondary malignancies, notably the development of acute myeloid leukemia in VP-16-treated patients. This association is suggestive of a link between carcinogenesis and Top2-mediated DNA damage. We show here that VP-16-induced carcinogenesis involves mainly the β rather than the α isozyme of Top2. In a mouse skin carcinogenesis model, the incidence of VP-16-induced melanomas in the skin of 7,12-dimethylbenz[ a ]anthracene-treated mice is found to be significantly higher in TOP2β + than in skin-specific top2 β-knockout mice. Furthermore, VP-16-induced DNA sequence rearrangements and double-strand breaks (DSBs) are found to be Top2β-dependent and preventable by cotreatment with a proteasome inhibitor, suggesting the importance of proteasomal degradation of the Top2β-DNA cleavage complexes in VP-16-induced DNA sequence rearrangements. VP-16 cytotoxicity in transformed cells expressing both Top2 isozymes is, however, found to be primarily Top2α-dependent. These results point to the importance of developing Top2α-specific anticancer drugs for effective chemotherapy without the development of treatment-related secondary malignancies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adriamycin-Induced DNA Damage Mediated by Mammalian DNA Topoisomerase II
Tewey, K. M., Rowe, T. C., Yang, L., Halligan, B. D., & Liu, L. F. (1984) · Science · doi:10.1126/science.6093249 · Cited by 1,538
Self-citationTkachuk, D. C., Kohler, S., & Cleary, M. L. (1992) · Cell · doi:10.1016/0092-8674(92)90602-9 · Cited by 920
Sonic hedgehog regulates growth and morphogenesis of the tooth
Dassule, H. R., Lewis, P., Bei, M., Maas, R., & McMahon, A. P. (2000) · Development · doi:10.1242/dev.127.22.4775 · Cited by 807
DNA topoisomerase II is required at the time of mitosis in yeast
HOLM, C., GOTO, T., WANG, J., & BOTSTEIN, D. (1985) · Cell · doi:10.1016/s0092-8674(85)80028-3 · Cited by 742
Self-citationDNA topoisomerase II is required for condensation and separation of mitotic chromosomes in S. pombe
Uemura, T., Ohkura, H., Adachi, Y., Morino, K., Shiozaki, K., & Yanagida, M. (1987) · Cell · doi:10.1016/0092-8674(87)90518-6 · Cited by 690
DiNardo, S., Voelkel, K., & Sternglanz, R. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.9.2616 · Cited by 674
Ziemin-van der Poel, S., McCabe, N. R., Gill, H. J., Espinosa, R., Patel, Y., Harden, A., Rubinelli, P., Smith, S. D., LeBeau, M. M., & Rowley, J. D. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10735 · Cited by 585
Etoposide, Topoisomerase II and Cancer
Baldwin, E., & Osheroff, N. (2005) · Current Medicinal Chemistry-Anti-Cancer Agents · doi:10.2174/1568011054222364 · Cited by 520
Tumor Cell Death Induced by Topoisomerase-Targeting Drugs
Li, T.-K., & Liu, L. F. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.53 · Cited by 508
Self-citationA trithorax–like gene is interrupted by chromosome 11q23 translocations in acute leukaemias
Djabali, M., Selleri, L., Parry, P., Bower, M., Young, B. D., & Evans, G. A. (1992) · Nature Genetics · doi:10.1038/ng1092-113 · Cited by 474
Involvement of nucleic acid synthesis in cell killing mechanisms of topoisomerase poisons.
D’Arpa, P., Beardmore, C., & Liu, L. F. (1990) · PubMed · Cited by 425
Self-citationSecondary leukemias induced by topoisomerase-targeted drugs
Felix, C. A. (1998) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(98)00139-0 · Cited by 418
THE CRITICAL ROLE OF CHROMOSOME TRANSLOCATIONS IN HUMAN LEUKEMIAS
Rowley, J. D. (1998) · Annual Review of Genetics · doi:10.1146/annurev.genet.32.1.495 · Cited by 397
Tsai-Pflugfelder, M., Liu, L. F., Liu, A. A., Tewey, K. M., Whang-Peng, J., Knutsen, T., Huebner, K., Croce, C. M., & Wang, J. C. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.19.7177 · Cited by 389
Self-citationBrown, D., Lydon, J., McLaughlin, M., Stuart-Tilley, A., Tyszkowski, R., & Alper, S. (1996) · Histochemistry and Cell Biology · doi:10.1007/bf01463929 · Cited by 321
A topoisomerase II-dependent G2 cycle checkpoint in mammalian cells
Downes, C. S., Clarke, D. J., Mullinger, A. M., Giménez-Abián, J. F., Creighton, A. M., & Johnson, R. T. (1994) · Nature · doi:10.1038/372467a0 · Cited by 317
Capranico, G., Tinelli, S., Austin, C. A., Fisher, M. L., & Zunino, F. (1992) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/0167-4781(92)90050-a · Cited by 258
Genetic pathways in therapy-related myelodysplasia and acute myeloid leukemia
Pedersen-Bjergaard, J., Andersen, M. K., Christiansen, D. H., & Nerlov, C. (2002) · Blood · doi:10.1182/blood.v99.6.1909 · Cited by 246
Interleukin 6: insights to its function in skin by overexpression in transgenic mice.
Turksen, K., Kupper, T., Degenstein, L., Williams, I., & Fuchs, E. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.11.5068 · Cited by 225
26 S Proteasome-mediated Degradation of Topoisomerase II Cleavable Complexes
Mao, Y., Desai, S. D., Ting, C.-Y., Hwang, J., & Liu, L. F. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104009200 · Cited by 196
Self-citationLeukemias related to treatment with DNA topoisomerase II inhibitors*
Felix, C. A. (2001) · Medical and Pediatric Oncology · doi:10.1002/mpo.1125 · Cited by 191
Cimino, G. G., Moir, D. T., Canaani, O. D., Williams, K. J., Crist, W., Katzav, S., Cannizzaro, L. A., Lange, B. J., Nowell̀, P. C., & Croce, C. M. (1991) · PubMed · Cited by 180
Role of Topoisomerase IIβ in the Expression of Developmentally Regulated Genes
Lyu, Y. L., Lin, C.-P., Azarova, A. M., Cai, L., Wang, J. C., & Liu, L. F. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00617-06 · Cited by 179
Self-citationStanulla, M., Wang, J., Chervinsky, D. S., Thandla, S., & Aplan, P. D. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.7.4070 · Cited by 178
Self-citationStrissel, P. L., Strick, R., Rowley, J. D., & Zeleznik‐Le, N. J. (1998) · Blood · doi:10.1182/blood.v92.10.3793 · Cited by 165
Aplan, P., Chervinsky, D., Stanulla, M., & Burhans, W. (1996) · Blood · doi:10.1182/blood.v87.7.2649.bloodjournal8772649 · Cited by 165
A Protease Pathway for the Repair of Topoisomerase II-DNA Covalent Complexes
Zhang, A., Lyu, Y. L., Lin, C., Zhou, N., Azarova, A. M., Wood, L. M., & Liu, L. F. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604149200 · Cited by 146
Self-citationAustin, C. A., Sng, J.-H., Patel, S., & Fisher, L. M. (1993) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/0167-4781(93)90215-y · Cited by 139
Aberrant lamination in the cerebral cortex of mouse embryos lacking DNA topoisomerase IIβ
Lyu, Y. L., & Wang, J. C. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1232376100 · Cited by 121
Self-citationInvolvement of DNA Topoisomerase IIβ in Neuronal Differentiation
Tsutsui, K., Tsutsui, K., Sano, K., Kikuchi, A., & Tokunaga, A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008517200 · Cited by 116
Betti, C. J., Villalobos, M. J., Díaz, M. O., & Vaughan, A. T. (2001) · PubMed · Cited by 103
Acidic pH induces topoisomerase II-mediated DNA damage
Xiao, H., Li, T., Yang, J., & Liu, L. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0935978100 · Cited by 96
Self-citationDomer, P. H., Head, D. R., Renganathan, N., Raimondi, S. C., Yang, E., & Atlas, M. (1995) · PubMed · Cited by 95
Lovett, B. D., Strumberg, D., Blair, I. A., Pang, S., Burden, D. A., Megonigal, M. D., Rappaport, E. F., Rebbeck, T. R., Osheroff, N., Pommier, Y. G., et al. (2001) · Biochemistry · doi:10.1021/bi002361x · Cited by 89
Topoisomerase II Is Required for Mitoxantrone to Signal Nuclear Factor κB Activation in HL60 Cells
Boland, M. P., Fitzgerald, K. A., & O'Neill, L. A. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.33.25231 · Cited by 74
Apoptotic stimuli initiate MLL-AF9 translocations that are transcribed in cells capable of division.
Betti, C. J., Villalobos, M. J., Dı́az, M. O., & Vaughan, A. T. (2003) · PubMed · Cited by 73
Cornarotti, M., Tinelli, S., Willmore, E., Zunino, F., Fisher, L. M., Austin, C. A., & Capranico, G. (1996) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09603-8 · Cited by 72
Nucleolytic Cleavage of the Mixed Lineage Leukemia Breakpoint Cluster Region during Apoptosis
Sim, S.-P., & Liu, L. F. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103962200 · Cited by 58
Self-citationHars, E. S., Lyu, Y. L., Lin, C., & Liu, L. F. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1724 · Cited by 48
Self-citationCharacterization of genomic breakpoints in MLL and CBP in leukemia patients with t(11;16)
Zhang, Y., Zeleznik‐Le, N. J., Emmanuel, N., Jayathilaka, N., Chen, J., Strissel, P. L., Strick, R., Li, L. S., Neilly, M. B., Taki, T., et al. (2004) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20077 · Cited by 28
Cited by
DNA Topoisomerases and Their Poisoning by Anticancer and Antibacterial Drugs
Pommier, Y., Leo, E., Zhang, H., & Marchand, C. (2010) · Chemistry & Biology · doi:10.1016/j.chembiol.2010.04.012 · Cited by 1,829
Targeting DNA topoisomerase II in cancer chemotherapy
Nitiss, J. L. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2607 · Cited by 1,791
Roles of eukaryotic topoisomerases in transcription, replication and genomic stability
Pommier, Y., Sun, Y., Huang, S.-Y. N., & Nitiss, J. L. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.111 · Cited by 950
Drugging Topoisomerases: Lessons and Challenges
Pommier, Y. (2013) · ACS Chemical Biology · doi:10.1021/cb300648v · Cited by 839
Lyu, Y. L., Kerrigan, J. E., Lin, C.-P., Azarova, A. M., Tsai, Y.-C., Ban, Y., & Liu, L. F. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1649 · Cited by 612
Self-citation
Metadata
- Authors
- Azarova, A. M., Lyu, Y. L., Lin, C.-P., Tsai, Y.-C., Lau, J. Y.-N., Wang, J. C., & Liu, L. F.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2007-06-26
- Volume
- 104
- Issue
- 26
- Pages
- 11014-11019
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2009057362
- Cited by
- 286
- References
- 40
- FWCI
- 5.39
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.